Apr 4, 2019 - Health

Justice Department alleges more drug copay kickbacks

A nurse prepares vials of the drug Solaris on a table.

Alexion, which makes Soliris, is paying a $13 million federal settlement. Photo: Rick Madonik/Toronto Star via Getty Images

Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals are paying a combined $122.6 million to the federal government to settle allegations that they funded outside charities that covered patients' copays for the specific drugs they sell.

Why it matters: It's illegal for pharmaceutical companies to directly or indirectly pay for patients' medications, because the payments are "masking the high prices those companies charge for their drugs,” U.S. Attorney Andrew Lelling said in a statement. Yet, copay kickback allegations continue to pop up.

Go deeper